ClinicalTrials.gg
CompletedNCT07879859MYOPAPUpdated Oct 19, 2026

Feasibility and Acceptability of a 6-Week Myofunctional and Physical Activity Program for University Students With Excessive Daytime Sleepiness

An interventional study of MYOPAP Program in Excessive Daytime Sleepiness and Disorders of Excessive Somnolence, sponsored by Kuwait University. Completed at 1 site in Kuwait. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-19.

Sponsored by Kuwait University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 7 months after the study started (first participant enrolled Feb 2026, registered Oct 2026).
Updated Oct 19, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
14
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The aim of this clinical trial is to examine the feasibility, acceptability and safety of a 6-week intervention (MYOPAP) which includes oropharyngeal myofunctional therapy, physical activity guidance, and sleep hygiene education in university students aged 18 years and older with excessive daytime sleepiness (Epworth Sleepiness Scale score greater than 10). The study will also explore changes in daytime sleepiness following the intervention and the feasibility of the procedures needed to inform future controlled trail.

The main questions it aims to answer are:

  • What proportion of participants complete the intervention?
  • What proportion adhere to the home exercises (at least 3 days per week)?
  • Do participants find the intervention acceptable, and what adverse events occur?

Participants will:

  • Attend one in-person session for consent, assessment, and instructions
  • Perform myofunctional exercises at home daily for 6 weeks
  • Follow physical activity and sleep hygiene recommendations
  • Report adherence through daily polls and weekly check-ins
  • Complete the Epworth Sleepiness Scale and an acceptability questionnaire at week 6
Read the detailed description

Design and setting: single-arm, pre-post pilot feasibility trial conducted at the Faculty of Allied Health Sciences, Kuwait University

Screening and recruitment: students were screened using an online survey incorporating the Epworth Sleepiness Scale (ESS). Those with ESS score > 10 were classified as having excessive daytime sleepiness and were contacted sequentially, in order of survey completion until the predetermined sample size was reached.

Intervention: the MYOPAP program consists of three components delivered over 6 weeks:

  1. Oropharyngeal myofunctional therapy, performed daily at home:

    • Tongue-to-palate suction hold: 10 repetitions with 5-second holds, twice daily
    • Anterior-to-posterior tongue slide: 10-15 repetitions, once daily
    • Posterior tongue press: 10-15 repetitions, once daily
    • Soft palate vowel phonation (nasal inhalation followed by a prolonged "A" sound): 10 repetitions, once daily
    • Buccinator suction: 10 repetitions, once daily
    • Buccinator resistance exercise: 5 repetitions per side, once daily
    • Alternating bilateral mastication with the tongue on the palate and lips sealed: at every meal
  2. Physical activity guidance:

    • Movement breaks: 2-3 minutes per hour during sedentary study periods
    • Pre-sleep relaxation stretching: 5-10 minutes nightly
    • Moderate-intensity brisk walking: 20-30 minutes, 3 days/week
  3. Sleep hygiene education:

    • Consistent sleep-wake schedule (within 30 minutes daily)
    • No screen use 60 minutes before sleep
    • No caffeine within 6 hours of bedtime
    • Bedroom environment optimization (quiet, dark, cool; phone away from bed)
    • Paced relaxation breathing (4-4-6 pattern): 5 minutes nightly

Delivery and monitoring: Instructions was provided in person at baseline with written and video materials, supplemented by daily reminder messages and weekly follow-up phone calls. adherence was monitored using daily electronic polls.

Feasibility benchmarks: Feasibility was evaluated against a priori benchmarks including retention of at least 80% of enrolled participants and at least 70% of participants rating the intervention as acceptable. Recruitment was reported descriptively.

02

Conditions studied

  • Excessive Daytime Sleepiness
  • Disorders of Excessive Somnolence

Keywords

  • Myofunctional therapy
  • Oropharyngeal Exercises
  • Sleep Hygiene
  • Physical Activity
  • Epworth Sleepiness Scale
  • University Students
  • Feasibility Studies
  • Pilot Study
03

In context

Disorders of Excessive Somnolence

195 studies on the registry are indexed under Disorders of Excessive Somnolence; 33 are open to participants now.

This study's enrollment of 14 is below the median of 86 across 158 interventional studies indexed under Disorders of Excessive Somnolence.

Browse Disorders of Excessive Somnolence studies →

Lead sponsor

Kuwait University is the lead sponsor of 14 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Undergraduate student enrolled in a college of the Health Sciences Center, Kuwait University
  • Epworth Sleepiness Scale (ESS) score greater than 10 on the screening questionnaire
  • Willing to participate in the 6-week MYOPAP program and the weekly follow-up sessions

Exclusion criteria

Exclusion Criteria:

  • ESS score of 10 or less
  • Current participation in a sleep-related treatment program (e.g., continuous positive airway pressure, oral appliance therapy, or supervised oropharyngeal therapy)
  • Known craniofacial, oropharyngeal, or neuromuscular condition that may limit performance of myofunctional exercises
  • Self-reported medical or psychiatric condition affecting sleep
  • Inability to understand or follow the study instructions
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
14 participants (actual)

Study arms

  • Experimental
    MYOPAP Intervention

    University students with excessive daytime sleepiness (ESS \>10) who received the 6-week MYOPAP program ( home-based oropharyngeal myofunctional exercises, physical activity guidance, and sleep hygiene education) supported by daily reminder messages and weekly follow-up phone calls.

    Behavioral: MYOPAP Program

Interventions

  • BehavioralMYOPAP Program

    A 6-week home-based multicomponent program delivered after an in-person instructional session with written and video materials. It consists of (1) seven oropharyngeal myofunctional exercises targeting the tongue, soft palate, and buccinator muscles, performed daily; (2) physical activity guidance including hourly movement breaks, nightly relaxation stretching, and brisk walking 3 days per week; and (3) sleep hygiene education including a consistent sleep-wake schedule, pre-sleep screen and caffeine restrictions, bedroom environment optimization, and paced relaxation breathing.

06

What researchers measure

Primary outcomes

  1. Retention Rate

    Proportion of enrolled participants who completed the 6- week program.

    Time frame: Baseline to week 6

  2. Adherence to the exercise program

    Proportion of participants who completed the myofunctional exercises on at least 3 days per week, monitored using daily electronic polls.

    Time frame: week 1 to 6

  3. Intervention acceptability

    Proportion of participants who somewhat or completely agreed with each item of a 9-item post-intervention acceptability questionnaire (5-point Likert scale scored 0-4, from completely disagree to completely agree).

    Time frame: Week 6

  4. Number of participants with Adverse Events

    Participants-reported adverse effects related to the intervention, recorded at weekly follow-up sessions.

    Time frame: Weeks 1 to 6

  5. Recruitment Rate

    Proportion of eligible students (ESS\>10) contacted who consented and enrolled in the study. Reported descriptively because of the sequential, capped recruitment design.

    Time frame: Recruitment period (3 weeks)

Secondary outcomes

  1. Change in Daytime Sleepiness

    Change in ESS total score from baseline to week 6 (exploratory).

    Time frame: Baseline and week 6

07

Study locations

1 site
  • Kuwait University
    Kuwait City, Kuwait, Kuwait
08

References and documents

Individual participant data

Plan to share: Yes — De-identified individual participant data underlying the published results will be available to qualified researchers upon reasonable request to the principal investigator, subject to approval by the HSC Ethics Committee for Student Research, Kuwait University.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 19, 2026
Show all 1 update
  1. Oct 19, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07879859
Lead sponsor
Kuwait University
Responsible party
Maryam Alemairi (Assistant Professor, Department of Physical Therapy, Kuwait University) — Principal investigator
First posted
Oct 19, 2026
Start date
Feb 15, 2026
Primary completion
Mar 29, 2026
Completion
Mar 29, 2026
Last update
Oct 19, 2026

Study contacts

Dr. Maryam Alemairi, PT, PhD
principal investigator · Kuwait University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion